Alvotech (ALVO) SEC Filings & Financial Intelligence
Alvotech (ALVO) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALVO
CIK: 1898416
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: N4
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte ehf.
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerSigny Magnusdottir
Audit LocationKopavogur, Iceland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-14 | 2026-10-14 | FORM 6-K | 0001171843-26-006617 | View SEC Doc Filr Page |
| 6-K | 2026-10-07 | 2026-10-06 | FORM 6-K | 0001171843-26-006489 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-05 | FORM 6-K | 0001171843-26-006383 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | FORM 6-K | 0001171843-26-005793 | View SEC Doc Filr Page |
| 6-K | 2026-08-21 | 2026-08-21 | FORM 6-K | 0001171843-26-005697 | View SEC Doc Filr Page |
| 6-K | 2026-08-19 | 2026-06-30 | 6-K | 0001628280-26-057988 | View SEC Doc Filr Page |
| 6-K | 2026-07-29 | 2026-07-29 | FORM 6-K | 0001171843-26-004991 | View SEC Doc Filr Page |
| 6-K | 2026-07-01 | 2026-07-01 | FORM 6-K | 0001171843-26-004413 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-30 | — | SCHEDULE 13D/A Filing | 0001213900-26-073903 | View SEC Doc Filr Page |
| 6-K | 2026-06-18 | 2026-06-18 | FORM 6-K | 0001171843-26-004194 | View SEC Doc Filr Page |
| 6-K | 2026-06-17 | 2026-06-16 | 6-K Filing | 0000930413-26-001867 | View SEC Doc Filr Page |
| 424B5 | 2026-06-16 | — | 424B5 Filing | 0000930413-26-001864 | View SEC Doc Filr Page |
| FWP | 2026-06-16 | — | FWP Filing | 0000930413-26-001861 | View SEC Doc Filr Page |
| FWP | 2026-06-15 | — | FWP Filing | 0000930413-26-001858 | View SEC Doc Filr Page |
| 424B5 | 2026-06-15 | — | 424B5 Filing | 0000930413-26-001857 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | 6-K Filing | 0000930413-26-001856 | View SEC Doc Filr Page |
| 6-K | 2026-06-08 | 2026-03-31 | FORM 6-K | 0001171843-26-003974 | View SEC Doc Filr Page |
| 6-K | 2026-06-04 | 2026-06-04 | FORM 6-K | 0001171843-26-003911 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-05-11 | FORM 6-K | 0001171843-26-003231 | View SEC Doc Filr Page |
| 6-K | 2026-05-04 | 2026-04-30 | FORM 6-K | 0001171843-26-002963 | View SEC Doc Filr Page |
| 20-F | 2026-03-31 | 2025-12-31 | 20-F | 0001898416-26-000004 | View SEC Doc Filr Page |
| 6-K | 2026-03-19 | 2025-12-31 | FORM 6-K | 0001171843-26-001773 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-12 | — | SCHEDULE 13D/A Filing | 0001936288-26-000004 | View SEC Doc Filr Page |
| 6-K | 2026-02-27 | 2026-02-27 | FORM 6-K | 0001171843-26-001168 | View SEC Doc Filr Page |
| 6-K | 2026-02-05 | 2026-02-05 | FORM 6-K | 0001171843-26-000641 | View SEC Doc Filr Page |